← Leaderboards
Martha J Morrell
Columbia University Health Sciences
$10,134,136
Attributed
$10,134,136
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,134,136 · 4
By mechanism
UH3$9,737,772 · 1
M01$396,364 · 3
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Edward V Nunes$88,947,598
- Yueqing Peng$2,078,163
- Salim S Abdool Karim$73,526,221
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchEpilepsyEnrollmentDiffusion Magnetic Resonance ImagingElectrophysiology (Science)Decision Support SystemsDesignBrainBiomarker DiscoveryBiophysical ModelEffective TherapyElementsBlindedComputational Network ModelingBilateralCohortBiological MarkersCentromedian Thalamic NucleusChildhoodClinical EfficacyClinical PracticeDetectionEarly ExperienceEvaluation
Grant awards (14)
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome$1,609,057
UH3 · FY2025 · NS · contact PI
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome$1,710,919
UH3 · FY2024 · NS · contact PI
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome$2,959,252
UH3 · FY2023 · NS · contact PI
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome$2,596,763
UH3 · FY2022 · NS · contact PI
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome$30,393
UH3 · FY2022 · NS · contact PI
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome$831,388
UH3 · FY2021 · NS · contact PI
BONE HEALTH IN EPILEPSY$1,935
M01 · FY2005 · RR
Bone Health in Epilepsy$6,943
M01 · FY2004 · RR
Reproductive Function in Women with Bipolar Disorders$1,666
M01 · FY2004 · RR
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS$192,910
M01 · FY2002 · RR
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS$192,910
M01 · FY2001 · RR
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS$0
M01 · FY2001 · RR
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS$0
M01 · FY2000 · RR
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS$0
M01 · FY2000 · RR